Victory Capital Management Inc Cytom X Therapeutics, Inc. Transaction History

Victory Capital Management Inc

$99 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 07, 2022	SELL	$3.87 - $7.39 $12.7 Million - $24.2 Million	-3,269,112 Closed	0 $0
Q3 2021 Nov 02, 2021	BUY	$4.32 - $6.43 $1.73 Million - $2.57 Million	400,126 Added 13.95%	3,269,112 $16.6 Million
Q2 2021 Aug 03, 2021	BUY	$6.33 - $9.91 $633,658 - $992,030	100,104 Added 3.62%	2,868,986 $18.2 Million
Q1 2021 May 04, 2021	BUY	$6.6 - $9.0 $2.98 Million - $4.06 Million	451,485 Added 19.48%	2,768,882 $21.4 Million
Q4 2020 Feb 01, 2021	SELL	$6.47 - $7.9 $714,346 - $872,231	-110,409 Reduced 4.55%	2,317,397 $15.2 Million
Q3 2020 Nov 09, 2020	BUY	$6.55 - $8.83 $988,041 - $1.33 Million	150,846 Added 6.62%	2,427,806 $16.1 Million
Q2 2020 Aug 07, 2020	SELL	$7.4 - $14.64 $3.67 Million - $7.25 Million	-495,466 Reduced 17.87%	2,276,960 $19 Million
Q1 2020 May 04, 2020	SELL	$3.61 - $8.6 $148,100 - $352,815	-41,025 Reduced 1.46%	2,772,426 $21.3 Million
Q4 2019 Feb 06, 2020	SELL	$5.17 - $8.91 $140,318 - $241,826	-27,141 Reduced 0.96%	2,813,451 $23.4 Million
Q4 2019 Feb 04, 2020	BUY	$5.17 - $8.91 $1.13 Million - $1.95 Million	218,470 Added 8.33%	2,840,592 $21.1 Million
Q3 2019 Nov 12, 2019	BUY	$7.38 - $12.25 $4.69 Million - $7.79 Million	636,132 Added 32.03%	2,622,122 $19.4 Million
Q2 2019 Aug 15, 2019	BUY	$9.35 - $11.41 $3.09 Million - $3.77 Million	330,460 Added 19.96%	1,985,990 $22.3 Million
Q1 2019 May 03, 2019	BUY	$9.5 - $19.16 $6.99 Million - $14.1 Million	735,320 Added 79.91%	1,655,530 $17.8 Million
Q4 2018 Feb 05, 2019	BUY	$12.69 - $18.61 $378,288 - $554,764	29,810 Added 3.35%	920,210 $13.9 Million
Q3 2018 Nov 01, 2018	BUY	$18.04 - $26.41 $13.9 Million - $20.4 Million	773,080 Added 658.95%	890,400 $16.5 Million
Q2 2018 Aug 02, 2018	SELL	$21.38 - $29.68 $143,459 - $199,152	-6,710 Reduced 5.41%	117,320 $2.68 Million
Q1 2018 May 04, 2018	BUY	$21.76 - $34.22 $2.7 Million - $4.24 Million	124,030 New	124,030 $3.53 Million

Others Institutions Holding CTMX

# of Institutions

Shares Held

50.7M

Call Options Held

112K

Put Options Held

8.3K

Tang Capital Management LLC San Diego, CA

7.81M
Shares

$8.28 Million
0.79% of portfolio
Bvf Inc San Francisco, CA

5.23M
Shares

$5.54 Million
0.2% of portfolio
Vanguard Group Inc Valley Forge, PA

5.16M
Shares

$5.47 Million
0.0% of portfolio
Janus Henderson Group PLC London, X0

4.81M
Shares

$5.1 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

3.1M
Shares

$3.29 Million
0.01% of portfolio

View Full List

About CytomX Therapeutics, Inc.

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $69.9M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

More about CTMX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account